ArticleBMC plant biology2026
Harnessing an endophytic Bacillus strain closely related to Bacillus velezensis for biocontrol of twig blight in bayberry caused by Pestalotiopsis versicolor.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTwig blight disease caused by Pestalotiopsis versicolor threatens bayberry (Myrica rubra) cultivation in China, prompting extensive reliance on chemical fungicides with limited long-term efficacy. This study investigated the potential of endophytic bacteria isolated from bayberry leaves as sustainable biocontrol agents against this pathogenic fungus.
resultsAn endophytic bacterium designated strain Bay9 was isolated from healthy bayberry leaves and identified as a Bacillus sp. closely related to Bacillus velezensis based on 16 S rRNA gene sequence analysis. Bay9 exhibited strong antifungal activity against P. versicolor in vitro and showed disease-suppressive effects under semi-controlled greenhouse conditions. On potato dextrose agar (PDA) and in potato dextrose broth (PDB), inhibition rates reached 74.44% and 87.65%, respectively, accompanied by severe ultrastructural damage to fungal hyphae observed by electron microscopy. Cell-free supernatants (CFSs) of Bay9 exhibited concentration-dependent antifungal activity, with inhibition rates of 15.77%, 34.99%, 66.74%, and 98.82% at concentrations of 2.5%, 5%, 10%, and 20% (v/v), respectively. CFSs at EC
conclusionsBay9 exhibited strong antifungal activity associated with multiple putative mechanisms, potentially involving siderophore production, hydrolytic enzyme activities (protease, amylase, and lipase), and lipopeptide-related metabolites, as suggested by biochemical assays and MALDI-TOF-MS-based tentative identification of surfactin-, iturin-, and fengycin-like compounds. Collectively, these findings suggest that Bay9 has potential as a biocontrol agent against P. versicolor under laboratory, detached-leaf, and semi-controlled greenhouse conditions. However, further studies are required to elucidate the underlying molecular mechanisms and to validate its efficacy under field conditions before practical application can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.